Characterization of mass ionizable degradation products of gliclazide by LC/ESI-MS

被引:7
作者
Bansal, Gulshan [1 ]
Singh, Manjeet [1 ]
Jindal, K. C.
Singh, Saranjit
机构
[1] Punjabi Univ, Dept Pharmaceut Sci & Drug Res, Patiala 147002, Punjab, India
关键词
degradation pathway; degradation products; gliclazide; LC/ESI-MS; mass fragmentation; stress testing;
D O I
10.1080/10826070802225585
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A solution containing six UV active degradation products (I-VI) of gliclazide formed under different stress conditions prescribed by International Conference on Harmonisation is analyzed by LC/ESI-MS. Of the six, four products I, II, V, and VI are detected in MS. The molecular weights of these are 171, 229, 337, and 321, respectively. The comparison of their mass fragmentation pattern with the drug has helped in establishment of their structures. These are identified as p-tolylsulfonamide (I), methyl N-(p-tolylsulfonyl)carbamate (II), 4,4a,5,6,7,7a-hexahydro-3H-cyclopenta[d]pyridazin-1-yl N-(p-tolylsulfonyl)carbamate (V), and N-(4,4a,5,6,7,7a-hexahydro-3H-cyclopenta[d]pyridazine-1-carbonyl)-4-methyl benzenesulfonamide (VI). It is indicated that product II is not a true degradation product, but a methyl ester formed in the presence of methanol, used to solubilize the drug in reaction solutions. Another product, which is not detected in LC/UV but showed up in the LC/MS chromatogram, is identified as (2-diazenylmethyl)cyclopentyl-methanol (VII). The pathways for the formation of these products are proposed.
引用
收藏
页码:2174 / 2193
页数:20
相关论文
共 34 条
[1]  
Baertschi S. W., 2005, PHARM STRESS TESTING
[2]   Forced degradation study on gliclazide and application of validated stability-indicating HPLC-UV method in stability testing of gliclazide tablets [J].
Bansal, Gulshan ;
Singh, Manjeet ;
Jindal, Kaur Chand .
CHROMATOGRAPHIA, 2007, 66 (9-10) :751-755
[3]   Comparison between liquid chromatography-UV detection and liquid chromatography-mass spectrometry for the characterization of impurities and/or degradants present in trimethoprim tablets [J].
Barbarin, N ;
Henion, JD ;
Wu, YH .
JOURNAL OF CHROMATOGRAPHY A, 2002, 970 (1-2) :141-154
[4]  
CASON J, 1966, PRINCIPLES MODERN OR
[5]  
Challis B., 1970, CHEM AMIDES
[6]   Applications of LC/MS in structure identifications of small molecules and proteins in drug discovery [J].
Chen, Guodong ;
Pramanik, Birendra N. ;
Liu, Yan-Hui ;
Mirza, Urooj A. .
JOURNAL OF MASS SPECTROMETRY, 2007, 42 (03) :279-287
[7]  
*COMM PROPR MED PR, 2004, CPMP GUID CONTR IMP
[8]   Mechanisms of acute and chronic hypoglycemic action of gliclazide [J].
da Tos, V ;
Maran, A ;
de Kreutzenberg, SV ;
Marchetto, S ;
Tadiotto, F ;
Bettio, M ;
Marescotti, MC ;
Tiengo, A ;
Del Prato, S .
ACTA DIABETOLOGICA, 2000, 37 (04) :201-206
[9]   Stability-indicating densitometric determination of some antidiabetic drugs in dosage forms, using TLC [J].
El Kousy, NM .
MIKROCHIMICA ACTA, 1998, 128 (1-2) :65-68
[10]   The use of hyphenated LC-MS technique for characterisation of impurity profiles during drug development [J].
Ermer, J .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (4-5) :707-714